Literature DB >> 9473515

Cloning and characterization of a novel human chemokine receptor.

P Fan1, H Kyaw, K Su, Z Zeng, M Augustus, K C Carter, Y Li.   

Abstract

The present study reports the identification of a human gene, HCR, which encodes a novel human chemokine receptor. The partial sequence of the HCR gene was first found in a human neutrophil cDNA library. With the use of an expressed sequence tag (EST) probe from the neutrophil library, the full length HCR cDNA was isolated. The open reading frame of HCR cDNA predicts a protein of 345 amino acids with seven transmembrane domain topography. The HCR gene exhibits good homology to human MIP-1a receptor with 43.1% amino acid identity and 64.4% amino acid similarity and also shows considerable sequence homology to other human chemokine receptors such as the MCP-3 receptor, MCP-5 receptor, and MCP-1 receptor. Northern blot analysis suggests that HCR gene is expressed abundantly in immunal tissues such as spleen, fetal liver, lymph node, and bone marrow. Strong expression was also found in human lung and heart. A chromosome mapping study indicated that HCR gene is positioned within human chromosome band Xq13. Our result suggests that HCR gene is a novel putative chemokine receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473515     DOI: 10.1006/bbrc.1997.7981

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.

Authors:  Teizo Yoshimura; Joost J Oppenheim
Journal:  Exp Cell Res       Date:  2010-11-04       Impact factor: 3.905

2.  Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells.

Authors:  Justin Monnier; Susanna Lewén; Edward O'Hara; Kexin Huang; Hua Tu; Eugene C Butcher; Brian A Zabel
Journal:  J Immunol       Date:  2012-06-13       Impact factor: 5.422

3.  CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.

Authors:  Marion Leick; Julie Catusse; Marie Follo; Robert J Nibbs; Tanja N Hartmann; Hendrik Veelken; Meike Burger
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

Review 4.  Chemerin: A comprehensive review elucidating the need for cardiovascular research.

Authors:  David J Ferland; Stephanie W Watts
Journal:  Pharmacol Res       Date:  2015-07-23       Impact factor: 7.658

Review 5.  Chemerin as an independent predictor of cardiovascular event risk.

Authors:  Sinan İnci; Gökhan Aksan; Pınar Doğan
Journal:  Ther Adv Endocrinol Metab       Date:  2016-02-08       Impact factor: 3.565

6.  Human B cells express the orphan chemokine receptor CRAM-A/B in a maturation-stage-dependent and CCL5-modulated manner.

Authors:  Tanja N Hartmann; Marion Leick; Susann Ewers; Andrea Diefenbacher; Ingrid Schraufstatter; Marek Honczarenko; Meike Burger
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

7.  Chemokine receptor-like 2 is involved in ischemic brain injury.

Authors:  Robert M Douglas; Alice H Chen; Alejandra Iniguez; Juan Wang; Zhengxing Fu; Frank L Powell; Gabriel G Haddad; Hang Yao
Journal:  J Exp Stroke Transl Med       Date:  2013-02-17

8.  High expression of CRAM correlates with poor prognosis in patients with cervical carcinoma.

Authors:  Teng Hou; Dongxia Liang; Dong Yang; Jiehua He; Yongwen Huang; Yanna Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

Review 9.  Atypical chemokine receptors.

Authors:  Maria Helena Ulvmar; Elin Hub; Antal Rot
Journal:  Exp Cell Res       Date:  2011-01-25       Impact factor: 3.905

Review 10.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.